Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose individualization in PharmDIS-e+.

J H Proost1, N C Punt

  • 1Department of Pharmacokinetics and Drug Delivery, Groningen, The Netherlands. j.h.proost@farm.rug.nl

International Journal of Clinical Pharmacology and Therapeutics
|January 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of haemodynamic- and electroencephalographic-monitored effects evoked by four combinations of effect-site concentrations of propofol and remifentanil, yielding a predicted tolerance to laryngoscopy of 90.

Journal of clinical monitoring and computing·2020
Same author

Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis.

Antimicrobial agents and chemotherapy·2017
Same author

Pharmacokinetic and pharmacodynamic interactions in anaesthesia. A review of current knowledge and how it can be used to optimize anaesthetic drug administration.

British journal of anaesthesia·2017
Same author

Probability to tolerate laryngoscopy and noxious stimulation response index as general indicators of the anaesthetic potency of sevoflurane, propofol, and remifentanil.

British journal of anaesthesia·2016
Same author

A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity.

British journal of clinical pharmacology·2016
Same author

Pharmacokinetics of Succinylated Serum Albumin in Wistar Rats and Cynomolgus Monkeys: Implications for Dosage Regimens in the Therapy of HIV Infection.

Drug delivery·2016
Same journal

Methotrexate and folic acid supplementation in rheumatoid arthritis: A Japanese claims database and 538,985 patients from April 2015 to November 2020.

International journal of clinical pharmacology and therapeutics·2026
Same journal

Cardiac arrest in an adolescent following an overdose of antidepressants comprising sertraline, quetiapine fumarate, and lamotrigine: Case report.

International journal of clinical pharmacology and therapeutics·2026
Same journal

Recombinant human growth hormone in pediatric patients using the FAERS database: Safety profile and update for the period 2004 - 2024.

International journal of clinical pharmacology and therapeutics·2026
Same journal

The triple neuromodulatory-immunomodulatory axis.

International journal of clinical pharmacology and therapeutics·2026
Same journal

Novel intravenous human IVIG in patients with secondary immunodeficiency: Interim analysis of a multicenter, prospective, non-interventional study.

International journal of clinical pharmacology and therapeutics·2026
Same journal

Network meta-analysis of bisphosphonates in the treatment of bone metastases from breast cancer.

International journal of clinical pharmacology and therapeutics·2026
See all related articles

Calculating individualized drug doses requires understanding drug properties and patient factors. The PharmDIS-e+ project developed a "PK and standard dose" approach for computerized dosing advice, improving upon complex PK-PD models.

Area of Science:

  • Pharmacology
  • Medical Informatics

Background:

  • Individualized drug dosage calculations depend on pharmacokinetic (PK) and pharmacodynamic (PD) properties, along with patient characteristics.
  • Current PK-PD based dosage regimens are often difficult to apply due to challenges in combining PK parameters and therapeutic targets for accurate prediction.

Purpose of the Study:

  • To develop an alternative, more applicable approach for computerized dosing advice.
  • To create user-friendly applications for healthcare professionals through the PharmDIS-e+ project.

Main Methods:

  • The PharmDIS-e+ project adopted a "PK and standard dose"-based principle as an alternative to traditional PK-PD models.
  • Focus on developing computerized applications for dosing regimen advice.

Main Results:

Related Experiment Videos

  • The "PK and standard dose" principle is well-suited for computerized dosing advice.
  • The project aims to provide practical tools for physicians and pharmacists.

Conclusions:

  • The PharmDIS-e+ project offers a simplified and effective method for drug dosage calculations.
  • This approach facilitates the development of applications for improved clinical decision-making in drug therapy.